Skip Navigation



Journal of Pediatric Psychology Advance Access published online on September 10, 2007
Journal of Pediatric Psychology, doi:10.1093/jpepsy/jsm066
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
32/9/1038    most recent
jsm066v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Butler, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, R. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Society of Pediatric Psychology. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Commentary: Lessons in Pediatric Neuropsycho-Oncology: What We’ve Learned since Johnny Gunther

Robert W. Butler, PhD, ABPP, Cn

Division of Pediatric Hematology/Oncology, Oregon Health & Science University

All correspondence concerning this article should be addressed to Robert W. Butler, PHD, ABPP, CN, Oregon Health & Science University, Division of Pediatric Hemotology/Oncology, 3181 SW Sam Jackson Park Road – CDRCP Portland, OR 97239. E-mail: butlerr@ohsu.edu

The first 10% of the full text of this article appears below.

In his paper, "Lessons in Pediatric Neuropsycho-Oncology: What We’ve Learned Since Johnny Gunther", Ris (2007Go) successfully accomplishes a formidable task. He provides a biographical and literary anchor that allows for the succinct summary of the history of neuro-oncological treatment, current status and standard of care, recent innovations and advances in the treatment of pediatric brain tumors. He also presents important information on current directions in both the measurement of neurocognitive late effects, and importantly, work that is being done to reduce the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?